Tag results:

STAT3

Targeting Cancer Stem Cells in Medulloblastoma by Inhibiting AMBRA1 Dual Function in Autophagy and STAT3 Signaling

[Acta Neuropathologica] Investigators identified a previously unrecognized role of the pro-autophagy factor AMBRA1 in regulating medulloblastoma .

DIF-1 Inhibits Growth and Metastasis of Triple-Negative Breast Cancer through AMPK-Mediated Inhibition of the mTORC1-S6K Signaling Pathway

[Oncogene] Scientists found that DIF-1 induced phosphorylation of AMPK and Raptor and dephosphorylation of p70S6K in multiple TNBC cell lines.

CIAPIN1 Accelerates Vascular Remodelling via p53 and JAK2-STAT3 Regulation in Vascular Smooth Muscle Cells

[British Journal of Pharmacology] Researchers used loss/gain-of-function approaches by gene delivery to determine whether cytokine induced apoptosis inhibitor 1 (CIAPIN1) modulated vascular smooth muscle cell proliferation, migration, and neointima formation, and to define the underlying mechanisms.

Stromal Induction of BRD4 Phosphorylation Results in Chromatin Remodeling and BET Inhibitor Resistance in Colorectal Cancer

[Nature Communications] Cancer-associated fibroblast-activated stromal signaling, interleukin-6/8-JAK2, induced BRD4 phosphorylation at tyrosine 97/98 in colorectal cancer, resulting in BRD4 stabilization due to interaction with the deubiquitinase UCHL3.

The Novel STAT3 Inhibitor WZ-2-033 Causes Regression of Human Triple-Negative Breast Cancer and Gastric Cancer Xenografts

[Acta Pharmacologica Sinica] WZ-2-033 significantly inhibited the proliferation, colony survival, migration, and invasion of TNBC cells and gastric cancer cells with aberrant signal transducer and activator of transcription 3 (STAT3) activation.

The HIF Target MAFF Promotes Tumor Invasion and Metastasis through IL11 and STAT3 Signaling

[Nature Communications] Investigators identified v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (MAFF) as a potent regulator of tumor invasion without affecting cell viability, and demonstrated the oncogenic role of MAFF as an activator of the IL11/STAT3 pathways in breast cancer.

Popular